Sawai Launches Tadalafil Tablets
2020-03-06 · Upsher-Smith Laboratories · original upsher-smith.com ↗
Osaka, Japan – March 6, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) announced the launch dates with the below-mentioned schedule for Tadalafil tablets (the branded product: Cialis®). Tadalafil tablets are prescribed for the treatment of erectile dysfunction. Product Name Launch Date TADALAFIL Tablets 10 mg CI [SAWAI] March 26, 2020 TADALAFIL Tablets 20 mg CI [SAWAI] March 19, 2020 The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States. Contact Information PR / IR Group, Corporate Strategy Department, Sawai Pharmaceutical Co., Ltd. E-mail: [email protected]
The release as fetched from its publisher. upsher-smith.com ↗